ZNF584

gene
On this page

Also known as FLJ39899

Summary

ZNF584 (zinc finger protein 584, HGNC:27318) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 584 (Q8IVC4). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 201514 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 61 total
  • MANE Select transcript: NM_173548

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27318
Approved symbolZNF584
Namezinc finger protein 584
Location19q13.43
Locus typegene with protein product
StatusApproved
AliasesFLJ39899
Ensembl geneENSG00000171574
Ensembl biotypeprotein_coding
Entrez201514

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 6 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay, 1 retained_intron

ENST00000306910, ENST00000322834, ENST00000593920, ENST00000594993, ENST00000596281, ENST00000596921, ENST00000598901, ENST00000599145, ENST00000599238, ENST00000703727, ENST00000703728, ENST00000703729

RefSeq mRNA: 3 — MANE Select: NM_173548 NM_001318002, NM_001363680, NM_173548

CCDS: CCDS12979, CCDS82414, CCDS86814

Canonical transcript exons

ENST00000306910 — 4 exons

ExonStartEnd
ENSE000011697925840994158410091
ENSE000031199745840864958409165
ENSE000035472095841552458415646
ENSE000035748515841681158418327

Expression profiles

Bgee: expression breadth ubiquitous, 202 present calls, max score 84.81.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.1079 / max 81.2498, expressed in 1673 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1778443.05841454
1778451.90591193
1778431.1436526

Top tissues by expression

246 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002384.81gold quality
secondary oocyteCL:000065583.11gold quality
stromal cell of endometriumCL:000225580.84gold quality
gastrocnemiusUBERON:000138880.12gold quality
hindlimb stylopod muscleUBERON:000425280.07gold quality
cortical plateUBERON:000534379.72gold quality
olfactory segment of nasal mucosaUBERON:000538679.66gold quality
tendon of biceps brachiiUBERON:000818879.60gold quality
muscle of legUBERON:000138379.52gold quality
right atrium auricular regionUBERON:000663179.28gold quality
heart left ventricleUBERON:000208479.25gold quality
cardiac ventricleUBERON:000208278.96gold quality
prefrontal cortexUBERON:000045178.86gold quality
right adrenal gland cortexUBERON:003582778.76gold quality
ventricular zoneUBERON:000305378.75gold quality
cardiac atriumUBERON:000208178.71gold quality
left adrenal gland cortexUBERON:003582578.24gold quality
right uterine tubeUBERON:000130278.21gold quality
heartUBERON:000094878.18gold quality
islet of LangerhansUBERON:000000678.10gold quality
left adrenal glandUBERON:000123478.02gold quality
right adrenal glandUBERON:000123377.94gold quality
skin of abdomenUBERON:000141677.88gold quality
skin of legUBERON:000151177.70gold quality
upper arm skinUBERON:000426377.58gold quality
lower esophagus muscularis layerUBERON:003583377.54gold quality
lower esophagusUBERON:001347377.51gold quality
esophagogastric junction muscularis propriaUBERON:003584177.48gold quality
adrenal cortexUBERON:000123577.43gold quality
descending thoracic aortaUBERON:000234577.24gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.94

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

25 targeting ZNF584, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-129999.7771.242389
HSA-MIR-556-3P99.7468.751203
HSA-MIR-4524A-3P99.7266.852406
HSA-MIR-452-5P99.6569.631762
HSA-MIR-4676-3P99.6569.311733
HSA-MIR-892C-3P99.6569.381745
HSA-MIR-429299.1665.571767
HSA-MIR-6791-5P99.1665.921844
HSA-MIR-465199.0667.572002
HSA-MIR-60898.9367.832013
HSA-MIR-5581-3P98.5570.311161
HSA-MIR-4684-5P98.2967.991650
HSA-MIR-4664-5P98.1765.071020
HSA-MIR-425397.4865.11692
HSA-MIR-6862-5P97.4864.84713
HSA-MIR-10400-3P97.2964.66597
HSA-MIR-467497.2964.62597
HSA-MIR-342-5P97.2564.10817
HSA-MIR-4433A-5P96.7965.01599
HSA-MIR-316596.1866.22473
HSA-MIR-6747-5P96.1764.99743
HSA-MIR-6735-3P96.1063.81600
HSA-MIR-3675-5P95.9065.80474
HSA-MIR-659-5P95.3665.00300
HSA-MIR-6890-5P92.8965.83442

Literature-anchored findings (GeneRIF, showing 1)

  • total of 1799 differentially methylated regions were identified including SLC6A3, Rab40C, ZNF584, and FOXD3 whose significant methylation differences were confirmed in breast cancer patients through quantitative real-time polymerase chain reaction.Methylation of those aforementioned genes in white blood cells of our young patients may highlight their potential as early epimarkers (PMID:28349825)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriozfxENSDARG00000074453
danio_rerioENSDARG00000098424
mus_musculusZfy2ENSMUSG00000000103
mus_musculusZfy1ENSMUSG00000053211
rattus_norvegicusZfy1ENSRNOG00000053042

Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)

Protein

Protein identifiers

Zinc finger protein 584Q8IVC4 (reviewed: Q8IVC4)

All UniProt accessions (6): Q8IVC4, F6W0P0, M0QZA3, M0R0A3, M0R2W6, M0R3F5

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (3): NP_001304931, NP_001350609, NP_775819* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352, PF13894

UniProt features (16 total): zinc finger region 8, region of interest 2, compositionally biased region 2, sequence variant 2, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IVC4-F165.170.05

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 75 (showing top): ROVERSI_GLIOMA_COPY_NUMBER_UP, DOUGLAS_BMI1_TARGETS_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ATF6_TARGET_GENES, BARX1_TARGET_GENES, CEBPZ_TARGET_GENES, CIITA_TARGET_GENES, E2F2_TARGET_GENES, FOXJ2_TARGET_GENES, HOXB4_TARGET_GENES, HOXB6_TARGET_GENES, ID2_TARGET_GENES, NAB2_TARGET_GENES, SUPT16H_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

318 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF584RNF225M0QZC1645
ZNF584SLC27A5Q9Y2P5568
ZNF584FBXL17Q9UF56501
ZNF584GNB5O14775482
ZNF584EXOC4Q96A65481
ZNF584LRRC61Q9BV99479
ZNF584MAP10Q9P2G4479
ZNF584FUT8Q9BYC5475
ZNF584TSNARE1Q96NA8449
ZNF584PDE4DQ08499448
ZNF584REEP3Q6NUK4438
ZNF584SGCZQ96LD1438
ZNF584SLC18B1Q6NT16433
ZNF584CLCC1Q96S66430
ZNF584NRXN1Q9ULB1426

IntAct

5 interactions, top by confidence:

ABTypeScore
LZTR1ZNF584psi-mi:“MI:0915”(physical association)0.370
ZNF584LRP4psi-mi:“MI:0914”(association)0.350
APPZNF584psi-mi:“MI:0915”(physical association)0.000

BioGRID (13): ZNF584 (Synthetic Lethality), ZNF584 (Affinity Capture-RNA), RNF41 (Affinity Capture-MS), MPP1 (Affinity Capture-MS), LRP4 (Affinity Capture-MS), CBX5 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), SORL1 (Affinity Capture-MS), SOGA1 (Affinity Capture-MS), ZNF584 (Affinity Capture-MS), ZNF584 (Two-hybrid), ZNF584 (Affinity Capture-RNA), ZNF584 (Two-hybrid)

ESM2 similar proteins: A0JPL0, A1L1L7, A3KN32, A3KN36, D3ZVT0, O43296, P08042, P16373, P17023, P17031, P52738, P85977, Q02975, Q12901, Q14592, Q29RZ4, Q3KNS6, Q4R6J4, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RB33, Q5RBY9, Q5T5D7, Q61751, Q61967, Q62396, Q6GQR8, Q6ZNG0, Q6ZS27, Q7Z398, Q8BI99, Q8BIQ3, Q8IVC4, Q8IZ26, Q8N988, Q8N9Z0, Q8NDP4

Diamond homologs: A0JPL0, A2VDP4, A3KN32, A6NFI3, A6NM28, A6QLU5, B2RXC5, B4DU55, O43296, O60765, O75290, O75467, P10072, P15622, P17014, P17023, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P52736, P52738, Q02975, Q06730, Q06732, Q14590, Q14929, Q16587, Q29RZ4, Q2TL60, Q3KNS6, Q3KQV3, Q49AA0, Q4R8H9, Q4V8A8, Q4V8E9, Q5FWF6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

61 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance52
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1035 predictions. Top by Δscore:

VariantEffectΔscore
19:58416809:AGAT:Aacceptor_gain1.0000
19:58416810:GATG:Gacceptor_gain1.0000
19:58408693:G:GTdonor_gain0.9900
19:58410088:CTGGG:Cdonor_loss0.9900
19:58410089:TGGG:Tdonor_loss0.9900
19:58410090:GG:Gdonor_gain0.9900
19:58410090:GGGTA:Gdonor_loss0.9900
19:58410091:GG:Gdonor_gain0.9900
19:58410091:GGTAA:Gdonor_loss0.9900
19:58410092:GTA:Gdonor_loss0.9900
19:58410093:TAAGT:Tdonor_loss0.9900
19:58415631:A:Tdonor_gain0.9900
19:58415644:TTGGT:Tdonor_loss0.9900
19:58415645:TGG:Tdonor_loss0.9900
19:58415646:GGT:Gdonor_loss0.9900
19:58415647:G:Cdonor_loss0.9900
19:58415647:G:GGdonor_gain0.9900
19:58415648:TAA:Tdonor_loss0.9900
19:58416806:TTCA:Tacceptor_loss0.9900
19:58416807:TCAG:Tacceptor_loss0.9900
19:58416808:CAGA:Cacceptor_loss0.9900
19:58416809:A:Cacceptor_loss0.9900
19:58409164:AGG:Adonor_loss0.9800
19:58409165:GGT:Gdonor_loss0.9800
19:58409167:T:Adonor_loss0.9800
19:58410088:CTGG:Cdonor_gain0.9800
19:58410092:G:GGdonor_gain0.9800
19:58410094:AA:Adonor_loss0.9800
19:58415519:CGCAG:Cacceptor_loss0.9800
19:58415520:GCAGG:Gacceptor_loss0.9800

AlphaMissense

2798 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:58417269:T:CF251L0.998
19:58417271:C:AF251L0.998
19:58417271:C:GF251L0.998
19:58417353:T:CF279L0.998
19:58417355:C:AF279L0.998
19:58417355:C:GF279L0.998
19:58417605:T:CF363L0.998
19:58417607:C:AF363L0.998
19:58417607:C:GF363L0.998
19:58417185:T:CF223L0.997
19:58417187:C:AF223L0.997
19:58417187:C:GF223L0.997
19:58417689:T:CF391L0.996
19:58417691:C:AF391L0.996
19:58417691:C:GF391L0.996
19:58417276:G:CR253P0.995
19:58417296:C:GH260D0.994
19:58417300:A:CQ261P0.994
19:58417464:C:GH316D0.994
19:58417550:C:AH344Q0.994
19:58417550:C:GH344Q0.994
19:58417214:C:AH232Q0.993
19:58417214:C:GH232Q0.993
19:58417296:C:AH260N0.993
19:58417298:C:AH260Q0.993
19:58417298:C:GH260Q0.993
19:58417464:C:AH316N0.993
19:58417540:T:CL341P0.993
19:58417562:C:AH348Q0.993
19:58417562:C:GH348Q0.993

dbSNP variants (sampled 300 via entrez): RS1000105963 (19:58401277 G>A,T), RS1000128585 (19:58418548 C>T), RS1000200275 (19:58401982 T>G), RS1000334326 (19:58404679 C>T), RS1000548299 (19:58414293 T>C,G), RS1000639841 (19:58410423 CTG>C), RS1000672793 (19:58404829 A>C), RS1000672879 (19:58406060 A>G), RS1000699732 (19:58409240 G>A), RS1000906462 (19:58411018 C>T), RS1001109400 (19:58408330 G>C), RS1001207276 (19:58411223 T>C), RS1001262655 (19:58411621 T>A), RS1001425981 (19:58406531 G>A,T), RS1001537580 (19:58414647 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST004058_2Uric acid clearance1.000000e-06
GCST90002402_577Platelet count1.000000e-20

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004761uric acid measurement
EFO:0004309platelet count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, affects cotreatment, increases abundance, increases expression2
Smokedecreases expression, increases abundance, increases expression2
Tobacco Smoke Pollutiondecreases expression, increases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
TAK-243increases sumoylation1
manganese chlorideincreases abundance, increases expression, affects cotreatment1
CGP 52608affects binding, increases reaction1
Air Pollutantsincreases abundance, increases expression1
Amiodaroneincreases expression1
Arsenicaffects cotreatment, increases abundance, increases expression1
Benzo(a)pyreneaffects methylation1
Doxorubicindecreases expression1
Estradiolincreases expression1
Manganeseincreases abundance, increases expression, affects cotreatment1
Methotrexatedecreases expression1
Methyl Methanesulfonateincreases expression1
Urethanedecreases expression1
Valproic Acidaffects expression1
Cadmium Chloridedecreases expression1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_HA04K562 eGFP-ZNF584Cancer cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.